In addition to its lipid-regulating role, this gene is reported to contribute to a reduction in weight gain, stored fat, and circulating lipids, with a low expression profile in the obese population [88], thus confirming the potential contribution of APOL2 and obesity to the pathogenesis of psychiatric diseases. The gene discussed is APOL2; the disease is psychiatric disorder.